While the number of new cases filed at district courts has declined through the year, analysis from RPX indicates that one key metric was up in the third quarter
Invalidation efforts in both China and the United States have come up short as the US chip giant faces Chinese infringement claims
The patent fund got leadership earlier this year, but willingness to litigate in its own name and work with assertion entities appears unchanged
Korean telco has started selling patents to other operating companies in the last two years, after previous deals focused on the NPE sector
Taiwan’s Personal Genomics is going after an acquisition target of Illumina, the top player in the sequencing space
The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate
Mastercard and the Bank of America may be investing heavily in their portfolios, but most traditional players favour company acquisitions and collaborations to stay in the game
Chinese court has had its say on royalties - and it looks like the telecoms giant has got exactly what it was looking for
Deal with Mediatek involves package of global families and comes months after Canadian licensing company’s deal with Nvidia
In its first patent transaction closed since designation on the entity list, Chinese firm buys from Silicon Valley inventor credited with first camera phone picture
Licensing business will take on company debt and needs to be “willing to litigate and litigate for years”
Research note points to favourable stay ruling from Ninth Circuit as sign that case is swinging the way of chip giant - this would also be a boon for other SEP licensors
Healthcare and pharma takes top spot by number of transactions, with Industrial following in second place; while IBM was the biggest seller in Q2
Assignment records show that assertion-focused North Dakota tribe recently picked up assets formerly owned by Intellectual Ventures and Korean smartphone business Pantech
This pair of consumer electronics powerhouses have risen to the top of their respective product categories in US, and both have achieved good IPR results along the way
